Document Detail


Anthroposophic vs. conventional therapy of acute respiratory and ear infections: a prospective outcomes study.
MedLine Citation:
PMID:  15926617     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
CONTEXT: Acute respiratory and ear symptoms are frequently treated with antibiotics. Anthroposophic treatment of these symptoms relies primarily on anthroposophic medications.
OBJECTIVE: To compare anthroposophic treatment to conventional treatment of acute respiratory and ear symptoms regarding clinical outcome, medication use and safety, and patient satisfaction.
DESIGN: Prospective, non-randomised comparison of outcomes in patients self-selected to anthroposophic or conventional therapy under real-world conditions.
SETTING: 29 primary care practices in Austria, Germany, Netherlands, UK, and USA. PARTICIPANTS AND THERAPY: 1016 consecutive outpatients aged > or = 1 month, consulting an anthroposophic (n = 715 A-patients) or conventional physician (n = 301 C-patients) with a chief complaint of acute (< or = 7 days) sore throat, ear pain, sinus pain, runny nose or cough. Patients were treated according to the physician's discretion.
PRIMARY OUTCOME: Patients' self-report of treatment outcome (complete recovery/major improvement/slight to moderate improvement/no change/deterioration) at Day 14.
RESULTS: Most common chief complaints were cough (39.9% of A-patients vs. 33.9% of C-patients, p = 0.0772), sore throat (26.3% vs. 23.3%, p=0.3436), and ear pain (20.0% vs. 18.9%, p=0.7302). Baseline chief complaint severity was severe or very severe in 60.5% of A-patients and 53.3% of C-patients (p=0.0444), mean severity (0-4) of complaint-related symptoms was 1.3 +/- 0.7 vs. 1.2 +/- 0.6 (p=0.5197). During the 28-day follow-up antibiotics were prescribed to 5.5% of A-patients and 33.6% of C-patients (p<0.0001), anthroposophic medicines were prescribed to all A-patients and no C-patient.
OUTCOMES: Improvement within 24 hours occurred in 30.9% (221/715) of A-patients and 16.6% (50/301) of C-patients (p<0.0001), improvement within 3 days in 73.1% and 57.1% (p<0.0001). At Day 7 complete recovery or major improvement was reported by 77.1% of A-patients and 66.1% of C-patients (p=0.0004), at Day 14 by 89.7% and 84.4% (p=0.0198). Complete recovery rates at Day 7 were 30.5% and 23.3% (p<0.0001); at Day 14 they were 64.2% and 49.5% (p<0.0001). 69.9% of A-patients and 60.5% of C-patients were very satisfied with their physician (p=0.0043); 95.7% and 83.4% would choose the same therapy again for their chief complaint (p<0.0001). After adjustment for country, gender, age, chief complaint, duration of complaint, previous episode of complaint within last year, and baseline symptom severity, odds ratios favoured the A-group for all these outcomes. Adverse drug reactions were reported in 2.7% of A-patients and 6.0% of C-patients (p=0.0157).
CONCLUSION: Compared to conventional treatment, anthroposophic treatment of primary care patients with acute respiratory and ear symptoms had more favourable outcomes, lower antibiotic prescription rates, less adverse drug reactions, and higher patient satisfaction.
Authors:
Harald J Hamre; Michael Fischer; Marianne Heger; David Riley; Max Haidvogl; Erik Baars; Eileen Bristol; Michael Evans; Reinhard Schwarz; Helmut Kiene
Related Documents :
8907347 - Long-term therapy with cytochrome c, flavin mononucleotide and thiamine diphosphate for...
14657187 - Phase-plane analysis of gaze stabilization to high acceleration head thrusts: a continu...
18825437 - Saccular function less affected than canal function in bilateral vestibulopathy.
18925527 - Relation between asymmetric dimethylarginine (adma) and hearing loss in patients with r...
17453357 - Nocardiosis in a tertiary care hospital in north india and review of patients reported ...
9409407 - Moyamoya disease in europe, past and present status.
Publication Detail:
Type:  Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Wiener klinische Wochenschrift     Volume:  117     ISSN:  0043-5325     ISO Abbreviation:  Wien. Klin. Wochenschr.     Publication Date:  2005 Apr 
Date Detail:
Created Date:  2005-06-01     Completed Date:  2005-06-24     Revised Date:  2011-08-25    
Medline Journal Info:
Nlm Unique ID:  21620870R     Medline TA:  Wien Klin Wochenschr     Country:  Austria    
Other Details:
Languages:  eng     Pagination:  256-68     Citation Subset:  IM    
Affiliation:
Institute for Applied Epistemology and Medical Methodology, Freiburg, Germany. harald.hamre@ifaemm.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Disease
Adolescent
Adult
Aged
Anthroposophy*
Anti-Bacterial Agents / adverse effects,  therapeutic use
Child
Child, Preschool
Female
Follow-Up Studies
Humans
Infant
Male
Middle Aged
Otitis Media / therapy*
Patient Satisfaction
Pharyngitis / therapy
Primary Health Care
Prospective Studies
Respiratory Tract Infections / therapy*
Sinusitis / therapy
Time Factors
Tonsillitis / therapy
Treatment Outcome
Chemical
Reg. No./Substance:
0/Anti-Bacterial Agents
Comments/Corrections
Comment In:
Wien Klin Wochenschr. 2005 Apr;117(7-8):239-40   [PMID:  15926613 ]
Wien Klin Wochenschr. 2005 Apr;117(7-8):241-2   [PMID:  15926614 ]
Wien Klin Wochenschr. 2005 Jul;117(13-14):500-1   [PMID:  16091879 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The metabolic syndrome: effects of a pronounced weight loss induced by bariatric surgery
Next Document:  Spectrum of germ-line MLH1 and MSH2 mutations in Austrian patients with hereditary nonpolyposis colo...